Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1

被引:130
作者
Okuyama, Hiroaki
Krishnamachary, Balaji
Zhou, Yi Fu
Nagasawa, Hideko
Bosch-Marce, Marta
Semenza, Gregg L.
机构
[1] Johns Hopkins Univ, Sch Med, Vasc Biol Program, Inst Cell Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA
关键词
D O I
10.1074/jbc.M602003200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone marrow-derived cells are recruited to sites of ischemia, where they promote tissue vascularization. This response is dependent upon the expression of vascular endothelial growth factor ( VEGF) receptor 1 ( VEGFR1), which mediates cell migration in response to VEGF or placental growth factor ( PLGF). In this study, we found that exposure of cultured mouse bone marrow-derived mesenchymal stromal cells ( MSC) to hypoxia or an adenovirus encoding a constitutively active form of hypoxia-inducible factor 1 ( HIF-1) induced VEGFR1 mRNA and protein expression and promoted ex vivo migration in response to VEGF or PLGF. MSCin which HIF-1 activity was inhibited by a dominant negative or RNA interference approach expressed markedly reduced levels of VEGFR1 and failed to migrate or activate AKT in response to VEGF or PLGF. Thus, loss-of-function and gain-of-function approaches demonstrated that HIF-1 activity is necessary and sufficient for basal and hypoxia-induced VEGFR1 expression in bone marrow-derived MSC.
引用
收藏
页码:15554 / 15563
页数:10
相关论文
共 64 条
[1]   Mobilizing endothelial progenitor cells [J].
Aicher, A ;
Zeiher, AM ;
Dimmeler, S .
HYPERTENSION, 2005, 45 (03) :321-325
[2]  
Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
[3]   Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation [J].
Annabi, B ;
Lee, YT ;
Turcotte, S ;
Naud, E ;
Desrosiers, RR ;
Champagne, M ;
Eliopoulos, N ;
Galipeau, J ;
Béliveau, R .
STEM CELLS, 2003, 21 (03) :337-347
[4]   Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors [J].
Aprelikova, O ;
Chandramouli, GVR ;
Wood, M ;
Vasselli, JR ;
Riss, J ;
Maranchie, JK ;
Linehan, WM ;
Barrett, JC .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (03) :491-501
[5]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[6]   VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells [J].
Asahara, T ;
Takahashi, T ;
Masuda, H ;
Kalka, C ;
Chen, DH ;
Iwaguro, H ;
Inai, Y ;
Silver, M ;
Isner, JM .
EMBO JOURNAL, 1999, 18 (14) :3964-3972
[7]   Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders [J].
Autiero, M ;
Luttun, A ;
Tjwa, M ;
Carmeliet, P .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1356-1370
[8]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[9]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[10]   A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia [J].
Brusselmans, K ;
Bono, F ;
Collen, D ;
Herbert, JM ;
Carmeliet, P ;
Dewerchin, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) :3493-3499